Objectives:
- Identify the current role for radiation therapy in the multi-modality treatment of newly diagnosed localized and advanced prostate cancers.
- Describe the potential benefits and risks of adjuvant ribociclib for patients with hormone receptor positive, HER2negative breast cancer
- Discuss current management of IDH-mutant gliomas
Zoom details:
Join from a PC, Mac, iPad, iPhone or Android device:
Please click this URL to join. https://uwmadison.zoom.us/s/91413316980?pwd=R0o4QTFJWU1IQ2NPU3E5dXVWRXFkUT09; Passcode: Grand
Or One tap mobile: +13017158592,,91413316980# US (Washington DC); +13052241968,,91413316980# US
Or join by phone:
Dial(for higher quality, dial a number based on your current location):
US: +1 301 715 8592 or +1 305 224 1968 or +1 309 205 3325 or +1 312 626 6799 or +1 646 931 3860 or +1 929 205 6099 or +1 386 347 5053 or +1 507 473 4847 or +1 564 217 2000 or +1 669 444 9171 or +1 669 900 6833 or +1 689 278 1000 or +1 719 359 4580 or +1 253 205 0468 or +1 253 215 8782 or +1 346 248 7799 or +1 360 209 5623; Webinar ID: 914 1331 6980; International numbers available: https://uwmadison.zoom.us/u/abTNhnM22S
Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East); Webinar ID: 914 1331 6980; Passcode: 971570
SIP: 91413316980@zoomcrc.com; Passcode: 971570
- 1.00 AAPA Category 1 CME
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 ACPE Contact Hours - Pharmacist Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™